JPWO2022255499A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022255499A5
JPWO2022255499A5 JP2023525939A JP2023525939A JPWO2022255499A5 JP WO2022255499 A5 JPWO2022255499 A5 JP WO2022255499A5 JP 2023525939 A JP2023525939 A JP 2023525939A JP 2023525939 A JP2023525939 A JP 2023525939A JP WO2022255499 A5 JPWO2022255499 A5 JP WO2022255499A5
Authority
JP
Japan
Prior art keywords
group
carboxamide
thiophene
formula
pharma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023525939A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022255499A1 (cg-RX-API-DMAC7.html
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/023390 external-priority patent/WO2022255499A1/ja
Publication of JPWO2022255499A1 publication Critical patent/JPWO2022255499A1/ja
Publication of JPWO2022255499A5 publication Critical patent/JPWO2022255499A5/ja
Pending legal-status Critical Current

Links

JP2023525939A 2021-06-04 2022-06-03 Pending JPWO2022255499A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021094481 2021-06-04
PCT/JP2022/023390 WO2022255499A1 (ja) 2021-06-04 2022-06-03 新規なamp活性化プロテインキナーゼ活性化剤

Publications (2)

Publication Number Publication Date
JPWO2022255499A1 JPWO2022255499A1 (cg-RX-API-DMAC7.html) 2022-12-08
JPWO2022255499A5 true JPWO2022255499A5 (cg-RX-API-DMAC7.html) 2025-06-09

Family

ID=84322602

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023525939A Pending JPWO2022255499A1 (cg-RX-API-DMAC7.html) 2021-06-04 2022-06-03

Country Status (5)

Country Link
US (1) US12622891B2 (cg-RX-API-DMAC7.html)
EP (1) EP4349331A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2022255499A1 (cg-RX-API-DMAC7.html)
CN (1) CN117794527A (cg-RX-API-DMAC7.html)
WO (1) WO2022255499A1 (cg-RX-API-DMAC7.html)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004043366A2 (en) 2002-11-06 2004-05-27 Smithkline Beecham Corporation Sulfonamides
TW200424174A (en) 2003-02-06 2004-11-16 Hoffmann La Roche New TP diamide
US20050090529A1 (en) 2003-07-31 2005-04-28 Pfizer Inc 3,5 Disubstituted indazole compounds with nitrogen-bearing 5-membered heterocycles, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
ES2328820T3 (es) 2003-10-17 2009-11-18 Astrazeneca Ab Derivados de 4-(pirazol-3-ilamino)pirimidina para uso en el tratamiento de cancer.
DE102004039876A1 (de) 2004-06-23 2006-01-26 Lanxess Deutschland Gmbh Herstellung von fluorierten 1,3-Benzodioxanen
JP2008007405A (ja) 2004-12-07 2008-01-17 Takeda Chem Ind Ltd カルボキサミド誘導体
CA2598458A1 (en) 2005-02-16 2006-08-24 Schering Corporation Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity
JP2011178728A (ja) 2010-03-02 2011-09-15 Kobe Univ Ampk活性化剤、glut4活性化剤、およびそれらを用いた医薬品・飲食品
JP2013212994A (ja) * 2010-06-22 2013-10-17 Sanwa Kagaku Kenkyusho Co Ltd 新規チオフェンカルボキサミド誘導体及びその医薬用途
US20130345243A1 (en) 2011-03-07 2013-12-26 Glaxosmithkline Llc 1h-pyrollo[3,2-d]pyrimidinedione derivatives
WO2014069426A1 (ja) * 2012-10-31 2014-05-08 塩野義製薬株式会社 Ampk活性化作用を有するベンズイミダゾールおよびアザベンズイミダゾール誘導体
CA2950119C (en) 2013-06-18 2021-09-14 Albert Einstein College Of Medicine, Inc. Treatment of obesity and pulmonary arterial hypertension
SG11201908817WA (en) 2017-03-21 2019-10-30 Fujifilm Corp Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound
JP7131034B2 (ja) 2018-03-30 2022-09-06 株式会社三洋物産 遊技機
JP7185226B2 (ja) * 2018-11-22 2022-12-07 国立大学法人 鹿児島大学 1,5-アンヒドロフルクトース誘導体を含むampk活性化剤
US11299582B2 (en) * 2019-04-29 2022-04-12 The Government Of The United States Of America, As Represented By The Secretary Of The Navy Breathable elastomeric composites with tether-containing conducting polymers for nanoscale diffusion control and protection

Similar Documents

Publication Publication Date Title
JP2016011316A (ja) カリケアマイシン誘導体のコンバージェント合成方法
Lee et al. Synthesis of 5-(7-hydroxyhept-3-enyl)-1, 2-dithiolan-3-one 1-oxide, a core functionality of antibiotic leinamycin
CN104892555A (zh) 曲前列尼尔中间体的制备方法
CN102126993A (zh) 白藜芦醇衍生物及其在制备抗癌药物中的应用
JP6407645B2 (ja) 芳香族化合物のパーフルオロアルキル化反応
Bosiak et al. Synthesis and photoluminescence properties of star-shaped 2, 3, 6, 7-tetrasubstituted benzo [1, 2-b: 4, 5-b′] difurans
CN106146418B (zh) 一种nh-1,2,3-三唑化合物的合成方法
JP5298636B2 (ja) ペンタフルオロスルファニル基を有する複素環オリゴマー化合物
JP2019089847A (ja) カリケアマイシン誘導体を合成するための中間体および方法
JP7672653B2 (ja) 化合物及びその製造方法
JP2015129098A (ja) 2,7置換[1]ベンゾチエノ[3,2−b][1]ベンゾチオフェン誘導体の製造方法
JP2017031097A (ja) ジチエノベンゾジフラン誘導体の製造方法
JP5305321B2 (ja) フルオロ化合物の製造方法
CN107603271B (zh) 一种长链烷氧基bodipy化合物的制备方法
CN101130529A (zh) 光学活性2,3-二羟基丁内半缩醛衍生物的制备方法
JP7301337B2 (ja) 化合物及びその製造方法
CN111100063B (zh) 一种合成2-氟甲基取代的吡咯烷、哌啶以及哌嗪衍生物的制备方法
CN121609690A (zh) 一种苯并噻吩-3-酮和3-氧取代苯并噻吩的一锅法合成方法
JP4780372B2 (ja) キノキサリンジオン誘導体及びその製造方法並びにその用途
JP5765371B2 (ja) ペンタフルオロスルファニル基を有する複素環オリゴマー化合物
KR101823271B1 (ko) 신규한 비대칭 상 이동 촉매 및 이를 이용한 알파-아미노산의 제조방법
US20050033090A1 (en) Process for the preparation of cinnamaldehyde compounds
JP4475901B2 (ja) 3−アセチルチオフェン類の製造方法
JP2024150858A (ja) 含フッ素ジアミン化合物の製造方法
CN103242176A (zh) 基于氯化胆碱的功能离子液体及其制备方法